Company / Shares Outstanding
ENDONOVO THERAPEUTICS, INC. Shares Outstanding History
FY2014-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
74.5M
FY2022
5-year range
431.1K / 317.0M
FY2018-FY2022
Trend
+203.6%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shares Outstanding changed +204% YoY in FY2022, a notable deviation from the 7-year average annual change of +1737%.
Based on SEC 10-K filings.
74498761.00 in FY2022 with a 3-year CAGR of +457.0%.
Increased from 1189204.00 to 74498761.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +457.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- ENDONOVO THERAPEUTICS, INC.'s shares outstanding has grown for 3 consecutive years.
- In FY2022, shares outstanding increased 203.6% year-over-year.
- Peak shares outstanding was recorded in FY2018.
- Lowest shares outstanding in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -76.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | 74.5M | +203.6% |
| FY2021 | 24.5M | +1963.3% |
| FY2020 | 1.2M | +175.9% |
| FY2019 | 431.1K | -99.9% |
| FY2018 | 317.0M | +202.4% |
| FY2016 | 104.8M | +28.7% |
| FY2015 | 81.4M | +9684.2% |
| FY2014 | 832.2K | - |
| FY2011 | - | - |
As of FY2022 · SEC 10-K · Updated Jun 29, 2026